Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to -$15.7 million.

  • Anika Therapeutics' Net Cash Flow rose 747.91% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year increase of 47.89%. This contributed to the annual value of -$15.7 million for FY2024, which is 15.67% down from last year.
  • Latest data reveals that Anika Therapeutics reported Net Cash Flow of -$15.7 million as of FY2024, which was down 15.67% from -$13.5 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Net Cash Flow registered a high of -$1.5 million during FY2021, and its lowest value of -$62.0 million during FY2020.
  • For the 3-year period, Anika Therapeutics' Net Cash Flow averaged around -$12.4 million, with its median value being -$13.5 million (2023).
  • Its Net Cash Flow has fluctuated over the past 5 years, first spiked by 97.58% in 2021, then slumped by 428.60% in 2022.
  • Over the past 5 years, Anika Therapeutics' Net Cash Flow (Yearly) stood at -$62.0 million in 2020, then skyrocketed by 97.58% to -$1.5 million in 2021, then tumbled by 428.60% to -$7.9 million in 2022, then crashed by 70.75% to -$13.5 million in 2023, then decreased by 15.67% to -$15.7 million in 2024.